Ocular Therapeutix Inc (OCUL)

Nov 20, 2024

Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 20, 2024

Nov 20, 2024

Ocular Therapeutix Q3 2024 Earnings Preview - MSN

Nov 20, 2024

Nov 17, 2024

(OCUL) Technical Data - Stock Traders Daily

Nov 17, 2024

Nov 16, 2024

Ocular Therapeutix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Nov 16, 2024

Nov 16, 2024

GSA Capital Partners LLP Takes Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Ocular Therapeutix (NASDAQ:OCUL) Given New $15.00 Price Target at HC Wainwright - MarketBeat

Nov 15, 2024

Nov 15, 2024

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: Strong Financial Position and ... - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Ocular Therapeutix Posts Mixed Third Quarter 2024 Results - Vision Monday

Nov 15, 2024

Nov 14, 2024

Ocular Therapeutix: Q3 Earnings Snapshot - Houston Chronicle

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix Reports Q3 2024 Financial Results - TipRanks

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix Inc. (OCUL) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Avoro Capital Advisors LLC Acquires Significant Stake in Ocular Therapeutix Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix Inc earnings beat by $0.02, revenue fell short of estimates - Investing.com

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix Inc Reports Q3 2024 Earnings: Revenue at $15. - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Q3 2024 Ocular Therapeutix Inc Earnings Call Transcript - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix appoints Namrata Saroj as CBO - The Pharma Letter

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights - The Manila Times

Nov 14, 2024

Nov 14, 2024

Ocular Therapeutix Inc. Appoints Namrata Saroj, OD, as Chief Business Officer - Vision Monday

Nov 14, 2024

Nov 13, 2024

A Peek at Ocular Therapeutix's Future Earnings - Benzinga

Nov 13, 2024

Nov 13, 2024

Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV - The Manila Times

Nov 13, 2024

Nov 13, 2024

What To Expect From Ocular Therapeutix Inc (OCUL) Q3 2024 Earnin - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Ocular Therapeutix™ to Present at the Jefferies London - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

What To Expect From Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Ocular Therapeutix appoints new Chief Business Officer By Investing.com - Investing.com Canada

Nov 12, 2024

Nov 12, 2024

Ocular Therapeutix appoints new Chief Business Officer - Investing.com

Nov 12, 2024

Nov 12, 2024

Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer - The Manila Times

Nov 12, 2024

Nov 07, 2024

Ocular Therapeutix (OCUL) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Nov 07, 2024

Nov 06, 2024

Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024 - GlobeNewswire

Nov 06, 2024

Nov 06, 2024

Rosalind Advisors Inc. Grows Holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Nov 06, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Ocular Therapeutix I - GuruFocus.com

Nov 05, 2024

Nov 02, 2024

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2024

Oct 28, 2024

Ocular Therapeutix stock soars to 52-week high of $11.64 By Investing.com - Investing.com South Africa

Oct 28, 2024

Oct 28, 2024

Ocular Therapeutix (NASDAQ:OCUL) Reaches New 1-Year HighHere's What Happened - MarketBeat

Oct 28, 2024

Oct 28, 2024

Ocular Therapeutix stock soars to 52-week high of $11.64 - Investing.com India

Oct 28, 2024

Oct 28, 2024

Short Interest in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Drops By 18.1% - MarketBeat

Oct 28, 2024

Oct 26, 2024

Assenagon Asset Management S.A. Makes New Investment in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Oct 26, 2024

Oct 21, 2024

Neuropathic Ocular Pain Pipeline Assessment 2024: Therapies, - openPR

Oct 21, 2024

Oct 21, 2024

Neuropathic Ocular Pain Pipeline Assessment 2024: Therapies, Clinical Trials, Therapies, and Key Companies Involved by DelveInsight | Ocular Therapeutix, Aldeyra Therapeutics, Aciex Therapeutics - Barchart

Oct 21, 2024

Oct 21, 2024

Allergic Conjunctivitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Bausch & Lomb Inc, Aldeyra Therapeutics, Vanda Pharma, OKYO - The Globe and Mail

Oct 21, 2024

Oct 20, 2024

Ocular Therapeutix (OCUL) Moves 6.1% Higher: Will This Strength Last? - MSN

Oct 20, 2024

Oct 20, 2024

HC Wainwright Reaffirms “Buy” Rating for Ocular Therapeutix (NASDAQ:OCUL) - Defense World

Oct 20, 2024

Oct 18, 2024

SG Americas Securities LLC Purchases Shares of 45,187 Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Oct 18, 2024

Oct 17, 2024

Ocular Therapeutix (NASDAQ:OCUL) Sets New 52-Week HighTime to Buy? - MarketBeat

Oct 17, 2024

Oct 16, 2024

Ocular Therapeutix stock soars to 52-week high of $11.34 - Investing.com

Oct 16, 2024

Oct 16, 2024

Ocular Therapeutix stock soars to 52-week high of $11.34 By Investing.com - Investing.com UK

Oct 16, 2024

Oct 16, 2024

Is Ocular Therapeutix (NASDAQ:OCUL) Weighed On By Its Debt Load? - Simply Wall St

Oct 16, 2024